Copyright Reports & Markets. All rights reserved.

Global Telmisartan Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Telmisartan Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Overview: Global Telmisartan Revenue by Type: 2015 VS 2019 VS 2025
      • 1.2.2 Injection
      • 1.2.3 Freeze-Dried Powder
    • 1.3 Market Analysis by Application
      • 1.3.1 Overview: Global Telmisartan Revenue by Application: 2015 VS 2019 VS 2025
      • 1.3.2 Hospital Use
      • 1.3.3 Clinic Use
      • 1.3.4 Others
    • 1.4 Overview of Global Telmisartan Market
      • 1.4.1 Global Telmisartan Market Status and Outlook (2015-2025)
      • 1.4.2 North America (United States, Canada and Mexico)
      • 1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
      • 1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      • 1.4.5 South America, Middle East & Africa
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Pfizer
      • 2.1.1 Pfizer Details
      • 2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.1.3 Pfizer SWOT Analysis
      • 2.1.4 Pfizer Product and Services
      • 2.1.5 Pfizer Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.2 Bayer
      • 2.2.1 Bayer Details
      • 2.2.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.2.3 Bayer SWOT Analysis
      • 2.2.4 Bayer Product and Services
      • 2.2.5 Bayer Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.3 Novartis
      • 2.3.1 Novartis Details
      • 2.3.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.3.3 Novartis SWOT Analysis
      • 2.3.4 Novartis Product and Services
      • 2.3.5 Novartis Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.4 Teva
      • 2.4.1 Teva Details
      • 2.4.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.4.3 Teva SWOT Analysis
      • 2.4.4 Teva Product and Services
      • 2.4.5 Teva Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.5 Hema Pharmaceuticals Pvt
      • 2.5.1 Hema Pharmaceuticals Pvt Details
      • 2.5.2 Hema Pharmaceuticals Pvt Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.5.3 Hema Pharmaceuticals Pvt SWOT Analysis
      • 2.5.4 Hema Pharmaceuticals Pvt Product and Services
      • 2.5.5 Hema Pharmaceuticals Pvt Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.6 Boehringer Ingelheim
      • 2.6.1 Boehringer Ingelheim Details
      • 2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.6.3 Boehringer Ingelheim SWOT Analysis
      • 2.6.4 Boehringer Ingelheim Product and Services
      • 2.6.5 Boehringer Ingelheim Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.7 Astellas Pharma Inc
      • 2.7.1 Astellas Pharma Inc Details
      • 2.7.2 Astellas Pharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.7.3 Astellas Pharma Inc SWOT Analysis
      • 2.7.4 Astellas Pharma Inc Product and Services
      • 2.7.5 Astellas Pharma Inc Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.8 Reddy's Laboratories (UK)
      • 2.8.1 Reddy's Laboratories (UK) Details
      • 2.8.2 Reddy's Laboratories (UK) Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.8.3 Reddy's Laboratories (UK) SWOT Analysis
      • 2.8.4 Reddy's Laboratories (UK) Product and Services
      • 2.8.5 Reddy's Laboratories (UK) Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.9 Mylan
      • 2.9.1 Mylan Details
      • 2.9.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.9.3 Mylan SWOT Analysis
      • 2.9.4 Mylan Product and Services
      • 2.9.5 Mylan Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.10 GSK
      • 2.10.1 GSK Details
      • 2.10.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.10.3 GSK SWOT Analysis
      • 2.10.4 GSK Product and Services
      • 2.10.5 GSK Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.11 Nippon Boehringer Ingelheim
      • 2.11.1 Nippon Boehringer Ingelheim Details
      • 2.11.2 Nippon Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.11.3 Nippon Boehringer Ingelheim SWOT Analysis
      • 2.11.4 Nippon Boehringer Ingelheim Product and Services
      • 2.11.5 Nippon Boehringer Ingelheim Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.12 Beijing Wansheng Pharmaceutical
      • 2.12.1 Beijing Wansheng Pharmaceutical Details
      • 2.12.2 Beijing Wansheng Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.12.3 Beijing Wansheng Pharmaceutical SWOT Analysis
      • 2.12.4 Beijing Wansheng Pharmaceutical Product and Services
      • 2.12.5 Beijing Wansheng Pharmaceutical Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.13 Abbott
      • 2.13.1 Abbott Details
      • 2.13.2 Abbott Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.13.3 Abbott SWOT Analysis
      • 2.13.4 Abbott Product and Services
      • 2.13.5 Abbott Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
    • 2.14 Takeda
      • 2.14.1 Takeda Details
      • 2.14.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
      • 2.14.3 Takeda SWOT Analysis
      • 2.14.4 Takeda Product and Services
      • 2.14.5 Takeda Telmisartan Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

    3 Sales, Revenue and Market Share by Manufacturer

    • 3.1 Global Telmisartan Sales and Market Share by Manufacturer (2018-2019)
    • 3.2 Global Telmisartan Revenue and Market Share by Manufacturer (2018-2019)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Telmisartan Manufacturer Market Share in 2019
      • 3.3.2 Top 6 Telmisartan Manufacturer Market Share in 2019
    • 3.4 Market Competition Trend

    4 Global Market Analysis by Regions

    • 4.1 Global Telmisartan Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Telmisartan Sales and Market Share by Regions (2015-2020)
      • 4.1.2 Global Telmisartan Revenue and Market Share by Regions (2015-2020)
    • 4.2 North America Telmisartan Sales and Growth Rate (2015-2020)
    • 4.3 Europe Telmisartan Sales and Growth Rate (2015-2020)
    • 4.4 Asia-Pacific Telmisartan Sales and Growth Rate (2015-2020)
    • 4.5 South America Telmisartan Sales and Growth Rate (2015-2020)
    • 4.6 Middle East and Africa Telmisartan Sales and Growth Rate (2015-2020)

    5 North America by Country

    • 5.1 North America Telmisartan Sales, Revenue and Market Share by Country
      • 5.1.1 North America Telmisartan Sales and Market Share by Country (2015-2020)
      • 5.1.2 North America Telmisartan Revenue and Market Share by Country (2015-2020)
    • 5.2 United States Telmisartan Sales and Growth Rate (2015-2020)
    • 5.3 Canada Telmisartan Sales and Growth Rate (2015-2020)
    • 5.4 Mexico Telmisartan Sales and Growth Rate (2015-2020)

    6 Europe by Country

    • 6.1 Europe Telmisartan Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Telmisartan Sales and Market Share by Country (2015-2020)
      • 6.1.2 Europe Telmisartan Revenue and Market Share by Country (2015-2020)
    • 6.2 Germany Telmisartan Sales and Growth Rate (2015-2020)
    • 6.3 UK Telmisartan Sales and Growth Rate (2015-2020)
    • 6.4 France Telmisartan Sales and Growth Rate (2015-2020)
    • 6.5 Russia Telmisartan Sales and Growth Rate (2015-2020)
    • 6.6 Italy Telmisartan Sales and Growth Rate (2015-2020)

    7 Asia-Pacific by Regions

    • 7.1 Asia-Pacific Telmisartan Sales, Revenue and Market Share by Regions
      • 7.1.1 Asia-Pacific Telmisartan Sales and Market Share by Regions (2015-2020)
      • 7.1.2 Asia-Pacific Telmisartan Revenue and Market Share by Regions (2015-2020)
    • 7.2 China Telmisartan Sales and Growth Rate (2015-2020)
    • 7.3 Japan Telmisartan Sales and Growth Rate (2015-2020)
    • 7.4 Korea Telmisartan Sales and Growth Rate (2015-2020)
    • 7.5 India Telmisartan Sales and Growth Rate (2015-2020)
    • 7.6 Southeast Asia Telmisartan Sales and Growth Rate (2015-2020)
    • 7.7 Australia Telmisartan Sales and Growth Rate (2015-2020)

    8 South America by Country

    • 8.1 South America Telmisartan Sales, Revenue and Market Share by Country
      • 8.1.1 South America Telmisartan Sales and Market Share by Country (2015-2020)
      • 8.1.2 South America Telmisartan Revenue and Market Share by Country (2015-2020)
    • 8.2 Brazil Telmisartan Sales and Growth Rate (2015-2020)
    • 8.3 Argentina Telmisartan Sales and Growth Rate (2015-2020)

    9 Middle East & Africa by Countries

    • 9.1 Middle East & Africa Telmisartan Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East & Africa Telmisartan Sales and Market Share by Country (2015-2020)
      • 9.1.2 Middle East & Africa Telmisartan Revenue and Market Share by Country (2015-2020)
    • 9.2 Saudi Arabia Telmisartan Sales and Growth Rate (2015-2020)
    • 9.3 Turkey Telmisartan Sales and Growth Rate (2015-2020)
    • 9.4 Egypt Telmisartan Sales and Growth Rate (2015-2020)
    • 9.5 South Africa Telmisartan Sales and Growth Rate (2015-2020)

    10 Market Segment by Type

    • 10.1 Global Telmisartan Sales and Market Share by Type (2015-2020)
    • 10.2 Global Telmisartan Revenue and Market Share by Type (2015-2020)
    • 10.3 Global Telmisartan Price by Type (2015-2020)

    11 Global Telmisartan Market Segment by Application

    • 11.1 Global Telmisartan Sales Market Share by Application (2015-2020)
    • 11.2 Global Telmisartan Revenue Market Share by Application (2015-2020)
    • 11.3 Global Telmisartan Price by Application (2015-2020)

    12 Market Forecast

    • 12.1 Global Telmisartan Sales, Revenue and Growth Rate (2021-2025)
    • 12.2 Telmisartan Market Forecast by Regions (2021-2025)
      • 12.2.1 North America Telmisartan Market Forecast (2021-2025)
      • 12.2.2 Europe Telmisartan Market Forecast (2021-2025)
      • 12.2.3 Asia-Pacific Telmisartan Market Forecast (2021-2025)
      • 12.2.4 South America Telmisartan Market Forecast (2021-2025)
      • 12.2.5 Middle East & Africa Telmisartan Market Forecast (2021-2025)
    • 12.3 Telmisartan Market Forecast by Type (2021-2025)
      • 12.3.1 Global Telmisartan Sales Forecast by Type (2021-2025)
      • 12.3.2 Global Telmisartan Market Share Forecast by Type (2021-2025)
    • 12.4 Telmisartan Market Forecast by Application (2021-2025)
      • 12.4.1 Global Telmisartan Sales Forecast by Application (2021-2025)
      • 12.4.2 Global Telmisartan Market Share Forecast by Application (2021-2025)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology
      • 15.2 Data Source
      • 15.3 Disclaimer

      Market Overview
      The global Telmisartan market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 0.8% in the forecast period of 2020 to 2025 and will expected to reach USD 3521.8 million by 2025, from USD 3416.8 million in 2019.

      The Telmisartan market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

      Market segmentation
      Telmisartan market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

      By Type, Telmisartan market has been segmented into
      Injection
      Freeze-Dried Powder

      By Application, Telmisartan has been segmented into:
      Hospital Use
      Clinic Use
      Others

      Regions and Countries Level Analysis
      Regional analysis is another highly comprehensive part of the research and analysis study of the global Telmisartan market presented in the report. This section sheds light on the sales growth of different regional and country-level Telmisartan markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Telmisartan market.

      The report offers in-depth assessment of the growth and other aspects of the Telmisartan market in important countries (regions), including:
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, etc.)
      Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

      Competitive Landscape and Telmisartan Market Share Analysis
      Telmisartan competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Telmisartan sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Telmisartan sales, revenue and market share for each player covered in this report.

      The major players covered in Telmisartan are:
      Pfizer
      Bayer
      Novartis
      Teva
      Hema Pharmaceuticals Pvt
      Boehringer Ingelheim
      Astellas Pharma Inc
      Reddy's Laboratories (UK)
      Mylan
      GSK
      Nippon Boehringer Ingelheim
      Beijing Wansheng Pharmaceutical
      Abbott
      Takeda

      Among other players domestic and global, Telmisartan market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Telmisartan product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Telmisartan, with price, sales, revenue and global market share of Telmisartan in 2018 and 2019.
      Chapter 3, the Telmisartan competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Telmisartan breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
      Chapter 12, Telmisartan market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
      Chapter 13, 14 and 15, to describe Telmisartan sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now